Microbiota-Based Therapeutics as New Standard-of-Care Treatment for Recurrent Clostridioides difficile Infection.|https://dx.doi.org/10.1159/000535851
Advances in Therapeutic Strategies for the Management of Clostridioides difficile Infection.|https://dx.doi.org/10.3390/jcm13051331
The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridioides difficile infection and other potential indications: second edition of joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines.|https://dx.doi.org/10.1016/j.jhin.2024.03.001
The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridioides difficile infection and other potential indications: second edition of joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines.|https://dx.doi.org/10.1136/gutjnl-2023-331550
